ClinicalTrials.gg
CompletedNCT07903233Updated Oct 29, 2026

Adult Tonsillectomy Techniques: Blunt Dissection Vs Bipolar Radiofrequency

An interventional study of Blunt Dissection and Bipolar Radiofrequency in Tonsillitis Chronic and Tonsillitis Recurrent, sponsored by Tanta University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Tanta University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 5 months after the study started (first participant enrolled May 2023, registered Oct 2026).
Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to assess the effectiveness of bipolar radiofrequency techniques of tonsillectomy in adults.

Read the detailed description

Tonsillectomy is one of the commonest procedures performed in otorhinolaryngology, accounting 20%-40% of surgical procedures performed in this field.

The techniques of tonsillectomy can be broadly divided into 2 major categories: extracapsular (total tonsillectomy, subcapsular) and intracapsular (partial tonsillectomy). Intracapsular is also known as "subtotal," and this procedure is also referred to as tonsillotomy.

02

Conditions studied

  • Tonsillitis Chronic
  • Tonsillitis Recurrent

Browse trials for

Keywords

  • Tonsillectomy
  • Blunt dissection
  • Bipolar Radio frequency
03

In context

Tonsillitis

103 studies on the registry are indexed under Tonsillitis; 12 are open to participants now.

This study's enrollment of 56 is below the median of 100 across 87 interventional studies indexed under Tonsillitis.

Browse Tonsillitis studies →

Lead sponsor

Tanta University is the lead sponsor of 1,010 studies on the registry; 321 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age of 18 years and above.
  • Patients with chronic tonsillitis.
  • Patients with history of recurrent tonsillitis (7 infections over one year, 5 infections annually over 2 years or 3 infections annually over 3 years).

Exclusion criteria

Exclusion Criteria:

  • Age less than 18 years.
  • Medically unfit patients.
  • Patients with bleeding disorders.
  • Asthma exacerbation.
  • Persistent adenoid hypertrophy.
  • Active rheumatic heart diseases as patient won't be fit for general anesthesia.
  • Patients need tonsillectomy for in cases of suspected .
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Blunt Dissection

    Patients underwent blunt dissection tonsillectomy.

    Procedure: Blunt Dissection

  • Active comparator
    Bipolar Radiofrequency

    Patients underwent bipolar radiofrequency tonsillectomy.

    Procedure: Bipolar Radiofrequency

Interventions

  • ProcedureBlunt Dissection

    Patients underwent blunt dissection tonsillectomy.

  • ProcedureBipolar Radiofrequency

    Patients underwent bipolar radiofrequency tonsillectomy.

06

What researchers measure

Primary outcomes

  1. Intraoperative bleeding

    Intraoperative bleeding was evaluated by the amount of blood loss calculated by the following method: * Number of cotton balls used = a * Approximate amount of blood in a cotton ball = 2.5 ml * Amount of blood in cotton balls (b) = 2.5 X a * Amount of fluid (blood and known amount of used saline) collected from the suction bottle = c * Amount of used saline = d * Amount of blood in suction bottle (e) = (c-d) * Total amount of blood loss = (b+e)

    Time frame: From the start to the end of surgery (Up to 60 minutes)

Secondary outcomes

  1. Intraoperative time

    Intraoperative time was measured using a stopwatch from the start of incision till removal of the mouth gag.

    Time frame: During surgery, from the first incision until removal of the mouth gag (Up to 60 minutes)

  2. Degree of pain

    Degree of pain was assessed using the visual analogue scale (VAS). The distance was measured in millimetres and interpreted as follows: * 0 to 4 mm - No Pain * 5 to 44 mm - Mild Pain * 45 to 74 mm - Moderate Pain * 75 to 100 mm - Severe Pain VAS was also more convenient in monitoring pain progression; the patient could indicate the level of increased or decreased pain on the scale which could be compared with the earlier level of pain

    Time frame: 2 weeks postoperatively

07

Study locations

1 site
  • Tanta University
    Tanta, El-Gharbia 31527, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07903233
Lead sponsor
Tanta University
Responsible party
Ahmed Talaat Zeyada Abdelhalim (Resident of Otorhinolaryngology, Tanta University, Tanta, Egypt., Tanta University) — Principal investigator
First posted
Oct 29, 2026
Start date
May 1, 2023
Primary completion
Nov 1, 2024
Completion
Nov 1, 2024
Last update
Oct 29, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion